Navya Bellamkonda

MedicineImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 Egress”.

Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 Egress

Viruses(2021)10.3390/v13091748

N/A

0.406DataRank · unranked

14 citations

Divya Kapoor, Navya Bellamkonda, Chandrashekhar D. Patil, Deepak Shukla, Ghadah A. Karasneh

Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform

European Journal of Pharmaceutics and Biopharmaceutics(2022)10.1016/j.ejpb.2022.03.001

N/A

0.165DataRank · unranked

2 citations

Joshua Ames, David Bin-Chia Wu, Benjamin E. Ramirez, Navya Bellamkonda, Deepak Shukla +1 more

Immune Response to SARS-CoV-2 Vaccines

Biomedicines(2022)10.3390/biomedicines10071464

N/A

0DataRank · unranked

39 citations

Upendra P. Lambe, Sonali Sawant, Shyam Sundar Nandi, Chiranjib Chakraborty, Deepak Shukla +1 more